Abstract
Whether or not to maintain neuromuscular block in patients, young or elderly, is very much a matter of debate1 and is influenced by the type of anesthesia administered as well as the planned surgical procedure. Once the decision is made to administer a nondepolarizing neuromuscular blocking agent to an elderly patient, special consideration must be given to the potential for altered pharmacologic behavior in this patient population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gueret G, Rossignol B, Kiss G, et al. Is muscle relaxant necessary for cardiac surgery? Anesth Analg 2004;99:1330–1333.
Tomlinson BE, Irving D. The numbers of limb motor neurons in the human lumbosacral cord throughout life. J Neurol Sci 1977;34:213–219.
Kawamura Y, Okazaki H, O’Brien PC, et al. Lumbar motoneurons of man. I. Numbers and diameter histograms of alpha and gamma axons and ventral roots. J Neuropathol Exp Neurol 1977;36:853–860.
Young A, Stokes M, Crowe M. Size, and strength of the quadriceps muscles of old and young men. Clin Physiol 1985;5:145–154.
Lexell J, Taylor CC, Sjöström M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15-to 83-year-old men. J Neurol Sci 1988;84:275–294.
Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970;19: 653–663.
Doherty TJ, Brown WF. Age-related changes in the twitch contractile properties of human thenar motor units. J Appl Physiol 1997;82:93–101.
Frolkis VV, Martynenko OA, Zamostan VP. Aging of the neuromuscular apparatus. Gerontology 1976;22:244–279.
Oda K. Age changes of motor innervation and acetylcholine receptor distribution on human skeletal muscle fibres. J Neurol Sci 1984;66:327–338.
Martyn JA, White DA, Gronert GA, et al. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992;76:822–843.
Smith DO. Acetylcholine storage, release and leakage at the neuromuscular junction of mature adult and aged rats. J Physiol 1984;347:161–176.
Gronert GA. Disuse atrophy with resistance to pancuronium. Anesthesiology 1981;55:547–549.
Novak LP. Aging, total body potassium, fat-free mass and cell mass in males and females between ages of 18–85 years. J Gerontol 1972;27:438–443.
Ritschel WA. Pharmacokinetic approach to drug dosing in the aged. J Am Geriatr Soc 1976;24:344–354.
Matteo RS, Backus WW, McDaniel DD, et al. Pharmacokinetics and pharmacodynamics of d-tubocurarine and metocurine in the elderly. Anesth Analg 1985;64:23–29.
Lien CA, Matteo RS, Ornstein E, et al. Distribution, elimination and action of vecuronium in the elderly. Anesth Analg 1991;73:39–42.
Wood M. Plasma drug binding: implications for anesthesiologists. Anesth Analg 1986;65:786–804.
Cameron M, Donati F, Varin F. In vitro plasma protein binding of neuromuscular blocking agents in different subpopulations of patients. Anesth Analg 1995;81:1019–1025.
Duvaldestin P, Saada J, Berger JL, et al. Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology 1982;56:36–40.
Rupp SM, Castagnoli KP, Fisher DM, et al. Pancuronium and vecuronium pharmacokinetics and pharmacodynamics of vecuronium in younger and elderly adults. Anesthesiology 1987;67:45–49.
Ornstein E, Matteo RS, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of pipecuronium (Arduan) in elderly surgical patients. Anesth Analg 1992;74:841–844.
Dresner DL, Basta SJ, Ali HH, et al. Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia. Anesth Analg 1990;71: 498–502.
O’Hara DA, Fragen RJ, Shanks CA. The effects of age on the dose response curve of vecuronium in adults. Anesthesiology 1987;67:45–49.
Bevan DR, Fiset P, Balendran P, et al. Pharmacodynamic behavior of rocuronium in the elderly. Can J Anaesth 1993; 40:127–132.
Bell PF, Mirakhur RK, Clarke RSJ. Dose-response studies of atracurium, vecuronium and pancuronium in the elderly. Anaesthesia 1989;44:925–927.
Koscielniak-Nielsen ZJ, Bevan JC, Popovic V, et al. Onset of maximum neuromuscular block following succinylcholine or vecuronium in four age groups. Anesthesiology 1993; 79:229–234.
Rodeheffer RJ, Gerstenblith G, Becker LC, et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke work compensate for a diminished heart rate. Circulation 1984;69:203–213.
Sorooshian SS, Stafford MA, Eastwood NB, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. Anesthesiology 1996;84: 1083–1091.
Fisher DM, Rosen JI. A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants. Anesthesiology 1986; 65:286–291.
McLeod K, Hull CJ, Watson MJ. Effects of ageing on the pharmacokinetics of pancuronium. Br J Anaesth 1979;51: 435–438.
Cook RD, Freeman JA, Lai AA, et al. Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure. Anesth Analg 1991; 72:143–150.
Cashman JN, Luke JJ, Jones RM. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function. Br J Anaesth 1990;64:186–192.
Koscielniak-Nielsen ZJ, Law-Min JC, Donati F, et al. Doseresponse relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients. Anesth Analg 1992;74:845–850.
Caldwell JE, Canfell PC, Castagnoli KP, et al. The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide. Anesthesiology 1989;70: 7–12.
Bender AD. The effect of increasing age on the distribution of peripheral blood flow in man. J Am Geriatr Soc 1965; 13:192–198.
Leithe ME, Hermiller JB, Magorien RD, et al. The effect of age on central and regional hemodynamics. Gerontology 1984;30:240–246.
Kato R, Vassanelli P, Frontino G, et al. Variation in the activity of liver microsomal drug-metabolizing enzymes in rats in relation to age. Biochem Pharmacol 1964;13:1037–1051.
Bencini AF, Scaf AHJ, Sohn YJ, et al. Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 1986;58: 988–995.
d’Hollander AA, Massaux F, Nevelsteen M, et al. Agedependent dose-response relationship of Org NC45 in anaesthetized patients. Br J Anaesth 1982;54:653–656.
McCarthy G, Elliott P, Mirakhur RK, et al. Onset and duration of action of vecuronium in the elderly: comparison with adults. Acta Anaesth Scand 1992;36:383–386.
Cooper RA, Maddineni RK, Wierda JMKH, et al. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (ORG 9426) during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993;71:222–226.
Matteo RS, Ornstein E, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg 1993;77:1193–1197.
Baykara N, Solak M, Toker K. Predicting recovery from deep neuromuscular block by rocuronium in the elderly. J Clin Anesth 2003;15:328–333.
d’Hollander AA, Luyckx C, Barvais L, et al. Clinical evaluation of atracurium besylate requirements for a stable muscle relaxation during surgery: lack of age-related effects. Anesthesiology 1983;59:237–240.
Kent AP, Parker CJ, Hunter JM. Pharmacokinetics of atracurium and laudanosine in the elderly. Br J Anaesth 1989; 63:661–666.
Kitts JB, Fisher DM, Canfell PC, et al. Pharmacokinetics and pharmacodynamics of atracurium in the elderly. Anesthesiology 1990;72:272–275.
Parker CJ, Hunter JM, Snowdon SL. Effect of age, sex and anesthetic technique on the pharmacokinetics of atracurium. Br J Anaesth 1992;69:439–443.
Fisher DM, Canfell PC, Fahey MR, et al. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis vs. organ-based elimination. Anesthesiology 1986;65:6–12.
Kisor DF, Schmith VD, Wargin WA, et al. Importance of the organ-independent elimination of cisatracurium. Anesth Analg 1996;83:1065–1071.
Ornstein E, Lien CA, Matteo RS, et al. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Anesthesiology 1996;84:520–525.
Pühringer FK, Heier T, Dodgson M, et al. Double-blind comparison of the variability in spontaneous recovery of cisatracurium and vecuronium-induced neuromuscular block in adult and elderly patients. Acta Anesthesiol Scand 2002;46:364–371.
Maddineni VR, Mirakhur RK, McCoy EP, et al. Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. Br J Anaesth 1994;73; 609–612.
Goudsouzian N, Charravorti S, Denman W, et al. Prolonged mivacurium infusion in young and elderly adults. Can J Anaesth 1997;44:955–962.
Østergaard D, Viby-Mogensen J, Pedersen NA, et al. Pharmacokinetics and pharmacodynamics of mivacurium in young adult and elderly patients. Acta Anaesthesiol Scand 2002;46:684–691.
Maddineni VR, Mirakhur RK, McCoy EP. Plasma cholinesterase activity in elderly and young adults. Br J Anaesth 1994;72:497.
Hart PS, McCarthy GJ, Brown R, Lau M, Fisher DM. The effect of plasma cholinesterase activity on mivacurium infusion rates. Anesth Analg 1995;80:760–763.
Matteo RS, Young WL, Ornstein E, et al. Pharmacokinetics and pharmacodynamics of edrophonium in elderly surgical patients. Anesth Analg 1990;71:334–339.
McCarthy GJ, Mirakhur RK, Maddineni VR, et al. Dose-responses for edrophonium during antagonism of vecuronium block in young and older adult patients. Anaesthesia 1995;50:503–506.
Kitajima T, Ishii K, Ogata H. Edrophonium as an antagonist of vecuronium-induced neuromuscular block in the elderly. Anaesthesia 1995;50:359–361.
Young WL, Backus W, Matteo RS, et al. Pharmacokinetics and pharmacodynamics of neostigmine in the elderly. Anesthesiology 1984;61:A300.
McCarthy GJ, Cooper R, Stanley JC, et al. Dose-response relationships for neostigmine antagonism of vecuroniuminduced neuromuscular block in adults and the elderly. Br J Anaesth 1992;69:281–283.
De Mey JC, Rolly G, Blauwen ND. Doxacurium block is not influenced by age. J Clin Anesth 1995;7:453–456.
Young WL, Matteo RS, Ornstein E. Duration of action of neostigmine and pyridostigmine in the elderly. Anesth Analg 1988;67:775–778.
Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactileguided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 2002;96:45–50.
Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997; 86:765–771.
Stone JG, Matteo RS, Ornstein E, et al. Aging alters the pharmacokinetics of pyridostigmine. Anesth Analg 1995; 81:773–776.
Cronnelly R, Stanski DR, Miller RD, et al. Pyridostigmine kinetics with and without renal function. Clin Pharmacol Ther 1980;28:78–81.
Muravchick S, Owens WD, Felts JA. Glycopyrrolate and cardiac dysrhythmias in geriatric patients after reversal of neuromuscular blockade. Can Anaesth Soc J 1979;26: 22–25.
Owens WD, Waldbaum LS, Stephen CR. Cardiac dysrhythmias following reversal of neuromuscular blocking agents in the geriatric patient. Anesth Analg 1978;57:186–190.
Simpson KH, Smith RJ, Davies LF. Comparison of the effects of atropine and glycopyrrolate on cognitive function following general anesthesia. Br J Anaesth 1987;59:966–969.
Baraka A, Yared JP, Karam AM, et al. Glycopyrrolateneostigmine and atropine-neostigmine mixtures affect postanesthesia arousal times differently. Anesth Analg 1980;59: 431–434.
Berg H, Viby-Mogensen J, Roed Mortensen CR, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications: a prospective, randomized and blinded study of postoperative complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997;41:1095–1103.
Lunn JN, Hunter AR, Scott DB. Anaesthesia-related surgical mortality. Anaesthesia 1983;38:1090–1096.
Cooper AL, Leigh JM, Tring IC. Admissions to the intensive care unit after complications of anesthetic techniques over 10 years. Anaesthesia 1989;44:953–958.
Tiret L, Nivoche Y, Hatton F, Desmonts JM, Vourch G. Complications related to anesthesia in infants and children: a prospective survey in 40,240 anaesthetics. Br J Anaesth 1988;61:263–269.
Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997;87:1035–1043.
Sundman E, Witt H, Olsson R, et al. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000;92:977–984.
Wyon N, Joensen H, Yamamoto Y, Lindahl SG, Eriksson LI. Carotid body chemoreceptor function is impaired by vecuronium during hypoxia. Anesthesiology 1998;89:1471–1479.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lien, C.A., Suzuki, T. (2008). Relaxants and Their Reversal Agents. In: Silverstein, J.H., Rooke, G.A., Reves, J.G., McLeskey, C.H. (eds) Geriatric Anesthesiology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72527-7_18
Download citation
DOI: https://doi.org/10.1007/978-0-387-72527-7_18
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72526-0
Online ISBN: 978-0-387-72527-7
eBook Packages: MedicineMedicine (R0)